Ubs Asset Management Americas Inc Castle Biosciences Inc Transaction History

Ubs Asset Management Americas Inc

$477 Billion
Q2 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Castle Biosciences Inc stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 102,742 shares of CSTL stock, worth $2.33 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,742

Previous 68,031 51.02%

Holding current value

$2.33 Million

Previous $1.36 Million 54.08%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$15.8 - $21.98 $548,433 - $762,947	34,711 Added 51.02%	102,742 $2.1 Million
Q1 2025 May 19, 2025	BUY	$18.76 - $32.72 $37,763 - $65,865	2,013 Added 3.05%	68,031 $1.36 Million
Q4 2024 Feb 14, 2025	BUY	$26.52 - $34.67 $278,088 - $363,549	10,486 Added 18.88%	66,018 $1.76 Million
Q3 2024 Nov 14, 2024	SELL	$17.4 - $31.47 $10,509 - $19,007	-604 Reduced 1.08%	55,532 $1.58 Million
Q2 2024 Aug 13, 2024	BUY	$18.84 - $24.94 $458,716 - $607,239	24,348 Added 76.59%	56,136 $1.22 Million
Q1 2024 May 15, 2024	BUY	$18.06 - $25.3 $81,757 - $114,533	4,527 Added 16.61%	31,788 $704,000
Q3 2023 Nov 13, 2023	SELL	$13.28 - $20.3 $1.73 Million - $2.64 Million	-130,061 Reduced 82.67%	27,261 $460,000
Q1 2023 May 15, 2023	SELL	$19.47 - $28.49 $33,897 - $49,601	-1,741 Reduced 1.09%	157,322 $3.57 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $229,923 - $381,510	12,717 Added 8.69%	159,063 $3.74 Million
Q3 2022 Nov 14, 2022	SELL	$22.51 - $34.32 $243,243 - $370,861	-10,806 Reduced 6.88%	146,346 $3.82 Million
Q2 2022 Aug 12, 2022	SELL	$16.0 - $45.99 $330,864 - $951,027	-20,679 Reduced 11.63%	157,152 $3.45 Million
Q1 2022 May 16, 2022	SELL	$33.17 - $46.98 $312,196 - $442,175	-9,412 Reduced 5.03%	177,831 $7.98 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $335,447 - $580,377	8,588 Added 4.81%	187,243 $8.03 Million
Q3 2021 Nov 15, 2021	SELL	$60.13 - $77.6 $490,179 - $632,595	-8,152 Reduced 4.36%	178,655 $11.9 Million
Q2 2021 Aug 16, 2021	SELL	$50.07 - $76.78 $339,023 - $519,877	-6,771 Reduced 3.5%	186,807 $13.7 Million
Q1 2021 May 14, 2021	BUY	$58.92 - $97.33 $200,917 - $331,895	3,410 Added 1.79%	193,578 $13.3 Million
Q4 2020 Mar 01, 2021	SELL	$43.6 - $73.05 $3.01 Million - $5.04 Million	-68,969 Reduced 26.61%	190,168 $12.8 Million
Q3 2020 Nov 13, 2020	BUY	$38.47 - $52.03 $3.66 Million - $4.95 Million	95,058 Added 57.93%	259,137 $13.3 Million
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $231,825 - $365,498	8,498 Added 5.46%	164,079 $6.18 Million
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $3.59 Million - $5.53 Million	155,581 New	155,581 $4.64 Million

Others Institutions Holding CSTL

# of Institutions

165

Shares Held

27.2M

Call Options Held

Put Options Held

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $597M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Castle Biosciences Inc Transaction History